Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study

Published:2019-08-06 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Labaki Wassim W.,Gu Tian,Murray Susan,Curtis Jeffrey L.^ORCID,Yeomans Larisa,Bowler Russell P.,Barr R. Graham,Comellas Alejandro P.,Hansel Nadia N.,Cooper Christopher B.,Barjaktarevic Igor,Kanner Richard E.,Paine Robert,McDonald Merry-Lynn N.,Krishnan Jerry A.,Peters Stephen P.,Woodruff Prescott G.,O’Neal Wanda K.,Diao Wenqi,He Bei,Martinez Fernando J.,Standiford Theodore J.,Stringer Kathleen A.,Han MeiLan K.

Funder

U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute

University of Michigan Health System-Peking University Health Science Center Joint Institute for Translational and Clinical Research.

U.S. Department of Health & Human Services | National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-47761-w.pdf

Reference43 articles.

1. Vogelmeier, C. F. et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med 195, 557–582, https://doi.org/10.1164/rccm.201701-0218PP (2017).

2. Han, M. K. et al. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Lancet. Respir Med 5, 619–626, https://doi.org/10.1016/S2213-2600(17)30207-2 (2017).

3. Hurst, J. R. et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363, 1128–1138, https://doi.org/10.1056/NEJMoa0909883 (2010).

4. Coxson, H. O. et al. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study. Lancet Respir Med 1, 129–136, https://doi.org/10.1016/S2213-2600(13)70006-7 (2013).

5. Bowler, R. P. et al. New Strategies and Challenges in Lung Proteomics and Metabolomics. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc 14, 1721–1743, https://doi.org/10.1513/AnnalsATS.201710-770WS (2017).

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum metabolomics analysis of patients with chronic obstructive pulmonary disease and ‘frequent exacerbator’ phenotype;Molecular Medicine Reports;2024-06-13

2. Mendelian randomization with incomplete measurements on the exposure in the Hispanic Community Health Study/Study of Latinos;Human Genetics and Genomics Advances;2024-01

3. Insights into the Serum Metabolic Adaptations in Response to Inspiratory Muscle Training: A Metabolomic Approach Based on 1H NMR and UHPLC-HRMS/MS;International Journal of Molecular Sciences;2023-11-25

4. Plasma metabolomics and quantitative interstitial abnormalities in ever-smokers;Respiratory Research;2023-11-04

5. Update on metabolomic findings in COPD patients;ERJ Open Research;2023-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3